Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of TdaP vs Td Booster in Adults
NCT01033877Phase 3Completed
- Sponsor
- Statens Serum Institut
- Start
- Jan 2010
- Primary completion
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine in Tetanus, diphtheria, pertussis, sponsored by Statens Serum Institut. Started Jan 2010; status: completed.
02
Drugs
tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine
03
Conditions
Tetanusdiphtheriapertussis
Beyond the preview
Go deeper on NCT01033877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033877.